Literature DB >> 28540623

QSP Toolbox: Computational Implementation of Integrated Workflow Components for Deploying Multi-Scale Mechanistic Models.

Yougan Cheng1, Craig J Thalhauser1, Shepard Smithline1, Jyotsna Pagidala1, Marko Miladinov1, Heather E Vezina1, Manish Gupta1, Tarek A Leil1, Brian J Schmidt2.   

Abstract

Quantitative systems pharmacology (QSP) modeling has become increasingly important in pharmaceutical research and development, and is a powerful tool to gain mechanistic insights into the complex dynamics of biological systems in response to drug treatment. However, even once a suitable mathematical framework to describe the pathophysiology and mechanisms of interest is established, final model calibration and the exploration of variability can be challenging and time consuming. QSP models are often formulated as multi-scale, multi-compartment nonlinear systems of ordinary differential equations. Commonly accepted modeling strategies, workflows, and tools have promise to greatly improve the efficiency of QSP methods and improve productivity. In this paper, we present the QSP Toolbox, a set of functions, structure array conventions, and class definitions that computationally implement critical elements of QSP workflows including data integration, model calibration, and variability exploration. We present the application of the toolbox to an ordinary differential equations-based model for antibody drug conjugates. As opposed to a single stepwise reference model calibration, the toolbox also facilitates simultaneous parameter optimization and variation across multiple in vitro, in vivo, and clinical assays to more comprehensively generate alternate mechanistic hypotheses that are in quantitative agreement with available data. The toolbox also includes scripts for developing and applying virtual populations to mechanistic exploration of biomarkers and efficacy. We anticipate that the QSP Toolbox will be a useful resource that will facilitate implementation, evaluation, and sharing of new methodologies in a common framework that will greatly benefit the community.

Keywords:  optimization; ordinary differential equations; quantitative systems pharmacology; virtual patient; virtual population

Mesh:

Substances:

Year:  2017        PMID: 28540623     DOI: 10.1208/s12248-017-0100-x

Source DB:  PubMed          Journal:  AAPS J        ISSN: 1550-7416            Impact factor:   4.009


  53 in total

1.  Cytoscape: a software environment for integrated models of biomolecular interaction networks.

Authors:  Paul Shannon; Andrew Markiel; Owen Ozier; Nitin S Baliga; Jonathan T Wang; Daniel Ramage; Nada Amin; Benno Schwikowski; Trey Ideker
Journal:  Genome Res       Date:  2003-11       Impact factor: 9.043

2.  Mechanism-Based Pharmacokinetic/Pharmacodynamic Model for THIOMAB™ Drug Conjugates.

Authors:  Siddharth Sukumaran; Kapil Gadkar; Crystal Zhang; Sunil Bhakta; Luna Liu; Keyang Xu; Helga Raab; Shang-Fan Yu; Elaine Mai; Aimee Fourie-O'Donohue; Katherine R Kozak; Saroja Ramanujan; Jagath R Junutula; Kedan Lin
Journal:  Pharm Res       Date:  2014-12-02       Impact factor: 4.200

Review 3.  Merging systems biology with pharmacodynamics.

Authors:  Ravi Iyengar; Shan Zhao; Seung-Wook Chung; Donald E Mager; James M Gallo
Journal:  Sci Transl Med       Date:  2012-03-21       Impact factor: 17.956

Review 4.  Beyond peptides and mAbs--current status and future perspectives for biotherapeutics with novel constructs.

Authors:  Dalal AlDeghaither; Brandon G Smaglo; Louis M Weiner
Journal:  J Clin Pharmacol       Date:  2015-03       Impact factor: 3.126

5.  Preclinical to Clinical Translation of Antibody-Drug Conjugates Using PK/PD Modeling: a Retrospective Analysis of Inotuzumab Ozogamicin.

Authors:  Alison M Betts; Nahor Haddish-Berhane; John Tolsma; Paul Jasper; Lindsay E King; Yongliang Sun; Subramanyam Chakrapani; Boris Shor; Joseph Boni; Theodore R Johnson
Journal:  AAPS J       Date:  2016-05-19       Impact factor: 4.009

6.  Good Practices in Model-Informed Drug Discovery and Development: Practice, Application, and Documentation.

Authors:  S F Marshall; R Burghaus; V Cosson; S Y A Cheung; M Chenel; O DellaPasqua; N Frey; B Hamrén; L Harnisch; F Ivanow; T Kerbusch; J Lippert; P A Milligan; S Rohou; A Staab; J L Steimer; C Tornøe; S A G Visser
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2016-03-14

7.  A modeling analysis of the effects of molecular size and binding affinity on tumor targeting.

Authors:  Michael M Schmidt; K Dane Wittrup
Journal:  Mol Cancer Ther       Date:  2009-10       Impact factor: 6.261

8.  Antigen shedding may improve efficiencies for delivery of antibody-based anticancer agents in solid tumors.

Authors:  Youngshang Pak; Yujian Zhang; Ira Pastan; Byungkook Lee
Journal:  Cancer Res       Date:  2012-05-04       Impact factor: 12.701

9.  NIH Support for the Emergence of Quantitative and Systems Pharmacology.

Authors:  M Rogers; P Lyster; R Okita
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2013-04-10

10.  A General Network Pharmacodynamic Model-Based Design Pipeline for Customized Cancer Therapy Applied to the VEGFR Pathway.

Authors:  X-Y Zhang; M R Birtwistle; J M Gallo
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2014-01-15
View more
  25 in total

Review 1.  Translational Quantitative Systems Pharmacology in Drug Development: from Current Landscape to Good Practices.

Authors:  Jane P F Bai; Justin C Earp; Venkateswaran C Pillai
Journal:  AAPS J       Date:  2019-06-03       Impact factor: 4.009

2.  Towards a comprehensive assessment of QSP models: what would it take?

Authors:  Ioannis P Androulakis
Journal:  J Pharmacokinet Pharmacodyn       Date:  2022-08-13       Impact factor: 2.410

3.  Review of quantitative systems pharmacological modeling in thrombosis.

Authors:  Limei Cheng; Guo-Wei Wei; Tarek Leil
Journal:  Commun Inf Syst       Date:  2019-12-06

4.  QSP-IO: A Quantitative Systems Pharmacology Toolbox for Mechanistic Multiscale Modeling for Immuno-Oncology Applications.

Authors:  Richard J Sové; Mohammad Jafarnejad; Chen Zhao; Hanwen Wang; Huilin Ma; Aleksander S Popel
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-09-07

5.  A demonstration of modularity, reuse, reproducibility, portability and scalability for modeling and simulation of cardiac electrophysiology using Kepler Workflows.

Authors:  Pei-Chi Yang; Shweta Purawat; Pek U Ieong; Mao-Tsuen Jeng; Kevin R DeMarco; Igor Vorobyov; Andrew D McCulloch; Ilkay Altintas; Rommie E Amaro; Colleen E Clancy
Journal:  PLoS Comput Biol       Date:  2019-03-08       Impact factor: 4.475

6.  A Computational Model of Neoadjuvant PD-1 Inhibition in Non-Small Cell Lung Cancer.

Authors:  Mohammad Jafarnejad; Chang Gong; Edward Gabrielson; Imke H Bartelink; Paolo Vicini; Bing Wang; Rajesh Narwal; Lorin Roskos; Aleksander S Popel
Journal:  AAPS J       Date:  2019-06-24       Impact factor: 4.009

7.  A Survey of Software Tool Utilization and Capabilities for Quantitative Systems Pharmacology: What We Have and What We Need.

Authors:  Sergey Ermakov; Brian J Schmidt; Cynthia J Musante; Craig J Thalhauser
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2019-01-30

Review 8.  The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development.

Authors:  Zhengying Zhou; Jinwei Zhu; Muhan Jiang; Lan Sang; Kun Hao; Hua He
Journal:  Pharmaceutics       Date:  2021-05-12       Impact factor: 6.321

9.  Leveraging Quantitative Systems Pharmacology Approach into Development of Human Recombinant Follistatin Fusion Protein for Duchenne Muscular Dystrophy.

Authors:  Hoa Q Nguyen; Andrea Iskenderian; David Ehmann; Paul Jasper; Zhiwei Zhang; Haojing Rong; Devin Welty; Rangaraj Narayanan
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2020-06-20

10.  Combination therapy with T cell engager and PD-L1 blockade enhances the antitumor potency of T cells as predicted by a QSP model.

Authors:  Huilin Ma; Hanwen Wang; Richard J Sové; Jun Wang; Craig Giragossian; Aleksander S Popel
Journal:  J Immunother Cancer       Date:  2020-08       Impact factor: 13.751

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.